866-997-4948(US-Canada Toll Free)

Exiqon AS (EXQ) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 42 Pages


Exiqon AS (Exiqon) is a Denmark-based biotechnology company. It undertakes the development, manufacture and distribution of products for the diagnosis of cancer and gene expression analysis. The company develops its products through the combination of leading edge scientific expertise in gene expression with its proprietary Locked Nucleic Acids (LNA) technology. Exiqon\'s product line includes miRCURY RNA Isolation kits, microRNA, miRCURY LNA Universal RT microRNA PCR, mRNA PCR, In Situ hybridization, mRNA isolation and reagents. In addition to this, it also manufactures numerous types of probes used in the procedure. The company provides its products to drug developers, life science researchers and physicians developing personalized treatment for cancer in the medical healthcare industry. It operates in Denmark, the US, Australia, China, Italy, Japan, Korea, and New Zealand. Exiqon is headquartered in Vedbaek, Denmark.

The company\'s strategy is to enhance its position as a leading biotechnology company through the development of microRNA research and diagnostic tools with leading-edge products and services based on its proprietary LNA detection technology.

This report is a source for data, analysis and actionable intelligence on the Exiqon AS portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4

Exiqon A/S - Business Description 5

Key Facts 6
Exiqon A/S - Major Products and Services 7
Exiqon A/S Pipeline Products by Equipment Type 9
Exiqon A/S Pipeline Products by Development Stage 11
Exiqon A/S Pipeline Products by Therapy Area 13
Exiqon A/S Pipeline Products by Milestone Summary 15
Colon Cancer Recurrence Test 17
Colon Cancer Recurrence Test Product Status 17
Colon Cancer Recurrence Test Product Description 17
miRNA Assay - Colorectal Cancer 18
miRNA Assay - Colorectal Cancer Product Status 18
miRNA Assay - Colorectal Cancer Product Description 18
miRNA Assay - Colorectal Cancer Product Milestone 18
Product Institution Details 19
miRNA Test - Endometrial Cancer 20
miRNA Test - Endometrial Cancer Product Status 20
miRNA Test - Endometrial Cancer Product Description 20
miRNA Test - Endometrial Cancer Product Patent Details 20
miRNA Test - Lung Cancer 24
miRNA Test - Lung Cancer Product Status 24
miRNA Test - Lung Cancer Product Description 24
miRNA Test - Lung Cancer Product Patent Details 24
miRNAbiomarker - Cancer of Unknown Primary 28
miRNAbiomarker - Cancer of Unknown Primary Product Status 28
miRNAbiomarker - Cancer of Unknown Primary Product Description 28
miRNAbiomarker - Cancer of Unknown Primary Product Patent Details 28
Exiqon A/S - Key Competitors 32
Exiqon A/S - Key Employees 33
Exiqon A/S - Key Employee Biographies 34
Exiqon A/S - Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 37
Exiqon A/S, Recent Developments 37
Jun 14, 2012: Exiqon Launches Bioinformatics Tool For Design And Selection Of LNA Enhanced qPCR Assays For Combined Analysis Of Messenger RNA, MicroRNA And Other ncRNA 37
Oct 10, 2011: Exiqon Launches New Products For R&D Of LNA Based Drugs 37
Oct 07, 2011: Exiqon Completes Litigation Against Santaris Pharma 38
Sep 09, 2011: Exiqon And AROS Applied Biotechnology Sign Center Of Excellence Agreement 38
May 23, 2011: Exiqon Announces Presentation Of Results At 2011 ASCO Annual Meeting In Chicago 39
May 03, 2011: Exiqon Launches Pick-&-Mix microRNA qPCR Arrays 39
Apr 12, 2011: Exiqon Expands Distributor Network 39
Apr 04, 2011: Exiqon Reports Positive Results On Early Detection Of Colorectal Cancer In Blood 40
Feb 08, 2011: Exiqon To Present New Data At AACR Conference 40
Jan 12, 2011: Exiqon Releases Second Generation Human microRNA Inhibitor Libraries 40

Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Table


Exiqon A/S, Key Facts 1
Exiqon A/S Key Pipeline Products by Equipment Type 1
Exiqon A/S Key Pipeline Products by Therapy Area 1
Exiqon A/S Key Pipeline Products by Development Stage 1
Exiqon A/S, Key Facts 6
Exiqon A/S, Major Products and Services 7
Exiqon A/S Number of Pipeline Products by Equipment Type 9
Exiqon A/S Pipeline Products by Equipment Type 10
Exiqon A/S Number of Pipeline Products by Development Stage 11
Exiqon A/S Pipeline Products by Development Stage 12
Exiqon A/S Number of Pipeline Products by Therapy Area 13
Exiqon A/S Pipeline Products by Therapy Area 14
Exiqon A/S Number of Pipeline Products By Milestone Summary 15
Exiqon A/S Pipeline Products by Milestone Summary 16
Colon Cancer Recurrence Test - Product Status 17
Colon Cancer Recurrence Test - Product Description 17
miRNA Assay - Colorectal Cancer - Product Status 18
miRNA Assay - Colorectal Cancer - Product Description 18
miRNA Assay - Colorectal Cancer - Product Milestone 18
miRNA Test - Endometrial Cancer - Product Status 20
miRNA Test - Endometrial Cancer - Product Description 20
miRNA Test - Endometrial Cancer - Patent Details1 20
miRNA Test - Endometrial Cancer - Patent Details2 21
miRNA Test - Endometrial Cancer - Patent Details3 21
miRNA Test - Endometrial Cancer - Patent Details4 22
miRNA Test - Endometrial Cancer - Patent Details5 22
miRNA Test - Endometrial Cancer - Patent Details6 22
miRNA Test - Lung Cancer - Product Status 24
miRNA Test - Lung Cancer - Product Description 24
miRNA Test - Lung Cancer - Patent Details1 24
miRNA Test - Lung Cancer - Patent Details2 25
miRNA Test - Lung Cancer - Patent Details3 25
miRNA Test - Lung Cancer - Patent Details4 25
miRNA Test - Lung Cancer - Patent Details5 26
miRNA Test - Lung Cancer - Patent Details6 26
miRNAbiomarker - Cancer of Unknown Primary - Product Status 28
miRNAbiomarker - Cancer of Unknown Primary - Product Description 28
miRNAbiomarker - Cancer of Unknown Primary - Patent Details1 28
miRNAbiomarker - Cancer of Unknown Primary - Patent Details2 29
miRNAbiomarker - Cancer of Unknown Primary - Patent Details3 29
miRNAbiomarker - Cancer of Unknown Primary - Patent Details4 30
miRNAbiomarker - Cancer of Unknown Primary - Patent Details5 30
miRNAbiomarker - Cancer of Unknown Primary - Patent Details6 30
Exiqon A/S, Key Employees 33
Exiqon A/S, Key Employee Biographies 34
Exiqon A/S, Other Locations 35
Exiqon A/S, Subsidiaries 36

List of Chart


Exiqon A/S Pipeline Products by Equipment Type 9
Exiqon A/S Pipeline Products by Development Stage 11
Exiqon A/S Pipeline Products by Therapy Area 13
Exiqon A/S Pipeline Products by Milestone Summary 15

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *